Botulinum Toxin Type A

Known as: Clostridium Botulinum Toxin Type A, BoNT/A, Botulinum Toxins, Type A 
An injectable formulation of a neurotoxin derived through the fermentation of the Hall strain of Clostridium botulinum type A with neuromuscular… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
OBJECTIVE Botulinum toxin type A (BTX-A) has been reported to have analgesic effects independent of its action on muscle tone… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
How the widely used botulinum neurotoxin A (BoNT/A) recognizes and enters neurons is poorly understood. We found that BoNT/A… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
A new botulinum toxin type A free of complexing proteins (NT 201) was compared with BOTOX in patients with cervical dystonia by… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVES To determine the effect of botulinum toxin type A on calcitonin gene-related peptide secretion from cultured… (More)
Is this relevant?
Review
2003
Review
2003
The neurotoxin, botulinum toxin type A, has been used successfully, in some patients, as an analgesic for myofascial pain… (More)
Is this relevant?
Review
2000
Review
2000
Botulinum toxin type A (BTX-A) is increasingly being used for the treatment of childhood spasticity, particularly cerebral palsy… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
OBJECTIVE The object of this clinical experience was to evaluate the correlation between pericranial botulinum toxin type A… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
OBJECTIVE To assess the safety and efficacy of botulinum toxin type A (BOTOX; Allergan, Inc) in the prevention of migraine… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Spasticity is a disorder of excess muscle tone associated with CNS disease. We hypothesized that botulinum toxin, a neuromuscular… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
NEUROTRANSMITTER release is potently blocked by a group of structurally related toxin proteins produced by Clostridium botulinum1… (More)
Is this relevant?